Suppr超能文献

177Lu-DOTA-0-酪氨酸3-奥曲肽输注模型用于肽受体放射性核素治疗期间外渗的实时检测与特征分析

177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT.

作者信息

Mazzara Christophe, Salvadori Julien, Ritzenthaler Florian, Martin Simon, Porot Clémence, Imperiale Alessio

机构信息

Radiophysics, Institut de Cancérologie de Strasbourg Europe (ICANS), 17 rue Albert Calmette, 67093, Strasbourg, France.

Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France.

出版信息

EJNMMI Phys. 2022 May 3;9(1):33. doi: 10.1186/s40658-022-00466-y.

Abstract

PURPOSE

Given the recent and rapid development of peptide receptor radionuclide therapy (PRRT), increasing emphasis should be placed on the early identification and quantification of therapeutic radiopharmaceutical (thRPM) extravasation during intravenous administration. Herein, we provide an analytical model of Lu-DOTA0-Tyr3-octreotate (Lutathera) infusion for real-time detection and characterization of thRPM extravasation.

METHODS

For 33 Lutathera-based PRRT procedures using the gravity infusion method, equivalent dose rates (EDRs) were monitored at the patient's arm. Models of flow dynamics for nonextravasated and extravasated infusions were elaborated and compared to experimental data through an equivalent dose rate calibration. Nonextravasated infusion was modeled by assuming constant volume dilution of Lu activity concentration in the vial and Poiseuille-like laminar flow through the tubing and patient vein. Extravasated infusions were modeled according to their onset times by considering elliptically shaped extravasation region with different aspect ratios.

RESULTS

Over the 33 procedures, the peak of the median EDR was reached 14 min after the start of the infusion with a value of 450 µSv h. On the basis of experimental measurements, 1 mSv h was considered the empirical threshold for Lutathera extravasation requiring cessation of the infusion and start again with a new route of injection. According to our model, the concentration of extravascular activity was directly related to the time of extravasation onset and its duration, a finding inherent in the gravity infusion method. This result should be considered when planning therapeutic strategy in the case of RPM extravasation because the local absorbed dose for β-emitters is closely linked to activity concentration. For selected EDR values, charts of extravasated activity, volume, and activity concentration were computed for extravasation characterization.

CONCLUSION

We proposed an analytical model of Lutathera infusion and extravasation (gravity method) based on EDR monitoring. This approach could be useful for the early detection of thRPM extravasation and for the real-time assessment of activity concentration and volume accumulation in the extravascular medium.

摘要

目的

鉴于肽受体放射性核素治疗(PRRT)近期的快速发展,应更加重视静脉给药过程中治疗性放射性药物(thRPM)外渗的早期识别和定量。在此,我们提供了一种用于实时检测和表征thRPM外渗的镥 - DOTA0 - Tyr3 - 奥曲肽(Lutathera)输注分析模型。

方法

对于33例采用重力输注法的基于Lutathera的PRRT程序,在患者手臂监测等效剂量率(EDR)。阐述了未发生外渗和发生外渗输注的流动动力学模型,并通过等效剂量率校准与实验数据进行比较。未发生外渗的输注通过假设小瓶中镥活度浓度的恒定体积稀释以及类似泊肃叶的层流通过管道和患者静脉来建模。发生外渗的输注根据其开始时间进行建模,考虑具有不同纵横比的椭圆形外渗区域。

结果

在这33例程序中,输注开始后14分钟达到中位EDR峰值,值为450 μSv/h。基于实验测量,1 mSv/h被视为Lutathera外渗需要停止输注并重新开始新注射途径的经验阈值。根据我们的模型,血管外活度浓度与外渗开始时间及其持续时间直接相关,这是重力输注法固有的一个发现。在RPM外渗情况下规划治疗策略时应考虑这一结果,因为β发射体的局部吸收剂量与活度浓度密切相关。对于选定的EDR值,计算了用于外渗表征的血管外活度、体积和活度浓度图表。

结论

我们提出了一种基于EDR监测的Lutathera输注和外渗(重力法)分析模型。这种方法可能有助于早期检测thRPM外渗,并实时评估血管外介质中的活度浓度和体积累积。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51c4/9065226/19c2b60e75a7/40658_2022_466_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验